Covered recipient · General Payments record
EMILY CLAIRE LARSON
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$11,170.30
- Reported across 715 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,417.85 | 72 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $445.34 | 23 |
| ABBVIE INC. | $346.97 | 17 |
| GlaxoSmithKline, LLC. | $197.12 | 9 |
| PFIZER INC. | $119.79 | 6 |
| UCB, Inc. | $92.79 | 5 |
| Acerta Pharma LLC | $73.26 | 4 |
| E.R. Squibb & Sons, L.L.C. | $50.53 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.51 | 2 |
| Fresenius Kabi USA, LLC | $35.39 | 2 |
| Genentech USA, Inc. | $15.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (72)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.16 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139264 | CMS |
| ABBVIE INC. | $19.95 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139266 | CMS |
| ABBVIE INC. | $15.98 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139268 | CMS |
| ABBVIE INC. | $6.14 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139270 | CMS |
| ABBVIE INC. | $27.41 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139272 | CMS |
| ABBVIE INC. | $20.67 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139274 | CMS |
| ABBVIE INC. | $21.63 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139276 | CMS |
| ABBVIE INC. | $3.06 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139278 | CMS |
| ABBVIE INC. | $27.57 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139280 | CMS |
| ABBVIE INC. | $20.38 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139282 | CMS |
| ABBVIE INC. | $17.83 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139284 | CMS |
| ABBVIE INC. | $16.33 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139286 | CMS |
| ABBVIE INC. | $28.94 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139288 | CMS |
| ABBVIE INC. | $27.85 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139290 | CMS |
| ABBVIE INC. | $28.89 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139292 | CMS |
| ABBVIE INC. | $21.09 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139294 | CMS |
| ABBVIE INC. | $17.09 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104139296 | CMS |
| Amgen Inc. | $18.29 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629092 | CMS |
| Amgen Inc. | $24.28 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629098 | CMS |
| Amgen Inc. | $4.09 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629100 | CMS |
| Amgen Inc. | $17.81 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629102 | CMS |
| Amgen Inc. | $26.97 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629104 | CMS |
| Amgen Inc. | $25.72 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629106 | CMS |
| Amgen Inc. | $20.74 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629108 | CMS |
| Amgen Inc. | $18.04 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629110 | CMS |
| Amgen Inc. | $5.82 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629116 | CMS |
| Amgen Inc. | $20.61 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629120 | CMS |
| Amgen Inc. | $7.36 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629112 | CMS |
| Amgen Inc. | $15.73 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305813 | CMS |
| Amgen Inc. | $21.12 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629114 | CMS |
| Amgen Inc. | $29.90 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629118 | CMS |
| Amgen Inc. | $29.24 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629094 | CMS |
| Amgen Inc. | $5.50 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629096 | CMS |
| Amgen Inc. | $19.64 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305799 | CMS |
| Amgen Inc. | $29.13 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305801 | CMS |
| Amgen Inc. | $6.30 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305809 | CMS |
| Amgen Inc. | $24.88 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305803 | CMS |
| Amgen Inc. | $18.58 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305805 | CMS |
| Amgen Inc. | $26.12 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305807 | CMS |
| Amgen Inc. | $29.47 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117305811 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.10 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104767920 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.77 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105556962 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.04 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105664788 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105816201 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.74 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101267513 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.26 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101267519 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.53 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101267531 | CMS |
| Fresenius Kabi USA, LLC | $18.74 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146958043 | CMS |
| Fresenius Kabi USA, LLC | $16.65 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146958041 | CMS |
| Genentech USA, Inc. | $15.15 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133007213 | CMS |
| GlaxoSmithKline, LLC. | $22.86 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116297424 | CMS |
| GlaxoSmithKline, LLC. | $23.57 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116599485 | CMS |
| GlaxoSmithKline, LLC. | $18.86 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116493326 | CMS |
| GlaxoSmithKline, LLC. | $19.94 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116244828 | CMS |
| GlaxoSmithKline, LLC. | $20.61 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116275523 | CMS |
| GlaxoSmithKline, LLC. | $22.18 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116203724 | CMS |
| GlaxoSmithKline, LLC. | $23.47 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116578164 | CMS |
| GlaxoSmithKline, LLC. | $25.40 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116551459 | CMS |
| GlaxoSmithKline, LLC. | $20.23 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116507597 | CMS |
| Novartis Pharmaceuticals Corporation | $19.41 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087137564 | CMS |
| Novartis Pharmaceuticals Corporation | $22.10 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087137568 | CMS |
| PFIZER INC. | $19.58 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131024148 | CMS |
| PFIZER INC. | $24.42 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131053064 | CMS |
| PFIZER INC. | $20.82 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131341683 | CMS |
| PFIZER INC. | $17.82 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131775869 | CMS |
| PFIZER INC. | $19.71 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131757646 | CMS |
| PFIZER INC. | $17.44 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131872845 | CMS |
| UCB, Inc. | $17.71 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143072236 | CMS |
| UCB, Inc. | $18.90 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143072238 | CMS |
| UCB, Inc. | $21.09 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143072240 | CMS |
| UCB, Inc. | $19.51 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143072242 | CMS |
| UCB, Inc. | $15.58 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143072244 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.